Canyon Pharmaceuticals Report issue

For profit Phase 3 Phase 4
Founded: Columbia MD United States (2003)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2006
NCT00329433
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Canyon Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

desirudin (Ipravask) (3 trials)

prednisone (meticorten) (1 trial)

Drugs in Phase 3 Trials (1)

heparin (liquaemin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thrombocytopenia (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3